From Medscape Diabetes & Endocrinology

Coverage from the

American Thyroid Association (ATA) 88th Annual Meeting

October 03 - 07, 2018; Washington DC

October 03 - 07, 2018 Washington DC

ATA 2018 Thermal Ablation Approaches Similar in Efficacy for Benign Nodules Comparison of radiofrequency ablation, laser ablation, and high-intensity focused ultrasound showed the three approaches had similar efficacy for the treatment of benign thyroid nodules.
Medscape Medical News, October 18, 2018
ATA 2018 Selumetinib: No Benefit Boosting RAI for High Risk Thyroid Cancer Though previous research showed the MEK1/2 inhibitor could improve RAI effect, the phase 3 trial failed to reach its primary endpoint.
Medscape Medical News, October 16, 2018
ATA 2018 New RET Inhibitors Show Reduced Toxicities in Thyroid Cancer The precision-targeted therapies show early, encouraging signs of reduced toxicities for medullary, thyroid cancers.
Medscape Medical News, October 15, 2018

Conference News

ATA 2018 Thermal Ablation Approaches Similar in Efficacy for Benign Nodules
Medscape Medical News, October 18, 2018
ATA 2018 Selumetinib: No Benefit Boosting RAI for High Risk Thyroid Cancer
Medscape Medical News, October 16, 2018
ATA 2018 New RET Inhibitors Show Reduced Toxicities in Thyroid Cancer
Medscape Medical News, October 15, 2018
ATA 2018 Artificial Intelligence Gains Ground in Thyroid Nodule Diagnosis
Medscape Medical News, October 10, 2018

ATA 2018 Inadequate Thyroid Ultrasound a 'National Epidemic' in US
Medscape Medical News, October 9, 2018
ATA 2018 IGF1-Targeting Teprotumumab Tackles Thyroid Eye Disease
Medscape Medical News, October 5, 2018
ATA 2018 ATA Annual Meeting Includes Potpourri of Thyroid Topics
Medscape Medical News, October 3, 2018

Popular News from ATA 2017

Levothyroxine Dose Tweaks Don't Alter Symptoms in Hypothyroidism Patients randomized to target either low-normal or high-normal thyroid levels with levothyroxine treatment show no significant differences in cognitive, mood, or quality-of-life measures.
Medscape Medical News, Oct 25, 2017
Updated Gene-Classifier Test Pinpoints Benign Thyroid Nodules The latest version of the ThyroSeq gene-classifier test showed high negative predictive value in the classification of indeterminate thyroid nodules in a blinded, multicenter study.
Medscape Medical News, Oct 30, 2017
Long-term, Low-Dose Methimazole Reduces Hyperthyroidism Relapses Patients with Graves' disease randomized to a median of 8 years of treatment with methimazole showed a significantly reduced risk of relapse compared with shorter-term treatment.
Medscape Medical News, Oct 24, 2017

Medscape Diabetes© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

ATA 2017